3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Leukemia, Myeloid, Accelerated Phase
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia
5
Blast Crisis
5
Leukemia, Myeloid, Chronic-Phase
3
Leukemia, Myeloid, Acute
2
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
1
Neoplasms by Histologic Type
1
Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma
1
Leukemia, Myeloid
1
Hematologic Diseases
1
Burkitt Lymphoma
1
Bone Marrow Diseases
1
Interventions
fludarabine
7
Cyclophosphamide
7
fludarabine phosphate
4
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Busulfan
2
Bendamustine Hydrochloride
2
AP 1903 reagent
2
pembrolizumab
1
ibrutinib
1
Surveys and Questionnaires
1
CA-4948
1
Bone Marrow Transplantation
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immune System Diseases
×
ponatinib
×
1 year
×
Clear all
No trials found.